Process and Product Development Subcommittee


The Process and Product Development Subcommittee strives to:

  • Establish and communicate best practices in Process and Product Development (PPD) as it relates to therapeutic cell based products.
  • Assess emerging cell processing technologies and forecast their impact on the commercialization process.

Click here to view the full charter.

Projects and Objectives

  • Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. Click here to view upcoming webinars.
  • White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase credibility and visibility of the PPD and ISCT. Click here to view the published PPD white papers.
  • ISCT Annual Meeting: The PPD will be actively involved in the organization of the ISCT Annual Meeting. At least one session in the Strategies for Commercialization Track will be organized by this committee.




Committee Chair


Dominic Clark, PhD
Winston Salem, North Carolina

John Fink, MBA
Pall Corporation
Boston, MA, United States


Committee Members


Alireza Abazari, PhD
BioLife Solutions
Bothell, WA, United States

Eytan Abraham, PhD
Walkersville, MA, United States

Sasha Aleksic, MSc
Irvine Scientific
Irvine, CA, United States

Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute for Regenerative Medicine
Winston-Salem, NC, United States

Hyalker Amaral, MBA
Terumo BCT
Denver, CO, United States

Behnam Ahmadian Baghbaderani, PhD
Lonza Walkersville
Walkersville, MD, United States

Stefeno Baila, PhD
Anemocyte SRL
Gerenzano, Italy

Harvey Brandwein, PhD
Cook Regentec
Port Washington, NY, United States


Christopher Bravery, PhD
Advanced Biologicals Ltd.
London, United Kingdom

Scott Burger, MD
Advanced Cell & Gene Therapy
Chapel Hill, NC, United States
Kristen Franklin, MS, PMP
Thermo Fisher Scientific
Washington, DC, United States

Dominic Clarke, PhD
Charter Medical
Winston-Salem, NC, United States

Shannon Eaker, PhD
GE Healthcare 
Knoxville, TN, United States

David Fiorentini, MSc
Biological Industries
Beit-Haemek, Israel


Maya Fuerstenau-Sharp, PhD
Sartorius-Stedim Biotech
Gottingen, Germany

Clive Glover, PhD
Pall Life Sciences
Portsmouth, United Kingdom

Michael Herrler, PhD, MBA
BD Biosciences
La Jolla, CA, United States

Kara Levine, PhD
Bedford, MA, United States
Yonatan Lipsitz, PhD
Rubius Therapeutics 
Boston, MA, United States
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States
Grace O'Connell, PhD
UC Berkeley
Berkely, CA, United States

Steve Oh, PhD

Jean-Sébastien Parisse
Aseptic Technologies
Gembloux, Belgium

Alaina Schlinker, PhD
Lake Zurich, IL, United States


Michael Scott, PhD
BlueRock Therapeutics
Toronto, ON, Canada

David Smith, PhD
Hitachi Chemical Advanced Therapeutic Solutions (HCATS)
Allendale, NJ, United States


Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy